Invention Grant
- Patent Title: Nucleotide prodrug compounds and use
- Patent Title (中): 核苷酸前药化合物及用途
-
Application No.: US14428151Application Date: 2013-09-12
-
Publication No.: US09326991B2Publication Date: 2016-05-03
- Inventor: Lin Zhi , K. Raja Reddy
- Applicant: LIGAND PHARMACEUTICALS INC.
- Applicant Address: US CA San Diego
- Assignee: LIGAND PHARMACEUTICALS, INC.
- Current Assignee: LIGAND PHARMACEUTICALS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Knobbe, Martens, Olson & Bear LLP
- International Application: PCT/US2013/059507 WO 20130912
- International Announcement: WO2014/043380 WO 20140320
- Main IPC: C07H19/12
- IPC: C07H19/12 ; C07F9/6574 ; A61K31/7056 ; A61K45/06
Abstract:
Embodiments of the present invention include nucleoside 5′-monophosphate derivative compounds, their preparation and their uses. In some embodiments, nucleoside 5′-monophosphate derivative compounds are useful to treat viral infections.
Public/Granted literature
- US20150246068A1 NOVEL NUCLEOTIDE PRODRUG COMPOUNDS AND USE Public/Granted day:2015-09-03
Information query
IPC分类:
